Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

February 11, 2022

Conditions
Liver Biopsy
Interventions
DIAGNOSTIC_TEST

biopsy

Liver biopsy (LB) is essential for the diagnosis and evaluation of a variety of hepatic conditions, such as grading/staging of chronic liver disease secondary to alcohol, non-alcoholic steatohepatitis, viral hepatitis, hemochromatosis, Wilson's disease, cholestatic liver disease, as well as in elucidating the etiology of elevation in liver tests.

Trial Locations (1)

32803

Center for Interventional Endoscopy, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AdventHealth

OTHER

NCT04003766 - Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy | Biotech Hunter | Biotech Hunter